APA

Griffiths E. A., Brady W. E., Tan W., Vigil C. E., Thompson J. E., Ford L. A., Dickey N. M., L Bashaw H., Sperrazza J., Wetzler M. & Wang E. S. (20160801). A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemia. : Leukemia research.

Chicago

Griffiths Elizabeth A, Brady William E, Tan Wei, Vigil Carlos E, Thompson James E, Ford Laurie A, Dickey Noelle M, L Bashaw Heather, Sperrazza Jill, Wetzler Meir and Wang Eunice S. 20160801. A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemia. : Leukemia research.

Harvard

Griffiths E. A., Brady W. E., Tan W., Vigil C. E., Thompson J. E., Ford L. A., Dickey N. M., L Bashaw H., Sperrazza J., Wetzler M. and Wang E. S. (20160801). A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemia. : Leukemia research.

MLA

Griffiths Elizabeth A, Brady William E, Tan Wei, Vigil Carlos E, Thompson James E, Ford Laurie A, Dickey Noelle M, L Bashaw Heather, Sperrazza Jill, Wetzler Meir and Wang Eunice S. A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemia. : Leukemia research. 20160801.